The study tests a new drug, AGN-193408 SR, for people with a type of eye problem called open-angle glaucoma or ocular hypertension. These conditions cause high pressure inside the eye, which can lead to vision loss. The study checks if the drug is safe and works well. Participants are divided into different groups, with some receiving the drug and others not. The study is open-label, meaning everyone knows what treatment they are getting, but some parts are masked, meaning some details are hidden to prevent bias.

Key Points:

• Participants may need to stop their current eye pressure treatments during the study.
• Only people who have had cataract surgery at least four months ago (for certain groups) can join.
• The study excludes those with certain eye surgeries or medical histories.

If you are interested, make sure you can follow all the study rules and are aware of the time commitment and any risks involved. Always talk with your doctor to decide if joining a study is right for you.